We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Autoliv
ALV
$8.95B
| $3.2M | 0.07% |
37,747
-1,804
| -5% | -$143K |
|
327
Advance Auto Parts
AAP
$3.41B
| $3.16M | 0.07% |
21,105
-1,334
| -6% | -$206K |
|
328
TransDigm Group
TDG
$72.3B
| $3.15M | 0.07% |
14,419
-1,628
| -10% | -$343K |
|
329
Under Armour
UAA
$2.87B
| $3.14M | 0.07% |
78,386
| – | – |
|
330
Entergy
ETR
$50.2B
| $3.13M | 0.07% |
80,754
-4,546
| -5% | -$187K |
|
|
SNDK
331
DELISTED
SANDISK CORP
SNDK
| $3.12M | 0.07% |
49,011
-5,455
| -10% | -$443K |
|
332
CF Industries
CF
$17.9B
| $3.12M | 0.07% |
54,935
-3,585
| -6% | -$214K |
|
333
BorgWarner
BWA
$12.7B
| $3.11M | 0.07% |
58,378
-4,571
| -7% | -$233K |
|
334
DaVita
DVA
$14.6B
| $3.08M | 0.07% |
37,909
-2,523
| -6% | -$194K |
|
335
Federal Realty Investment Trust
FRT
$10.6B
| $3.07M | 0.07% |
20,761
| – | – |
|
|
HBI
336
DELISTED
Hanesbrands
HBI
| $3.07M | 0.07% |
91,700
-31,156
| -25% | -$944K |
|
|
GMCR
337
DELISTED
KEURIG GREEN MTN INC
GMCR
| $3.07M | 0.07% |
27,405
-1,621
| -6% | -$203K |
|
|
MDVN
338
DELISTED
MEDIVATION, INC.
MDVN
| $3.06M | 0.07% |
47,472
| – | – |
|
|
ALTR
339
DELISTED
Altera Corp
ALTR
| $3.06M | 0.07% |
71,192
-1,494
| -2% | -$53.4K |
|
340
Agilent Technologies
A
$38.8B
| $3.04M | 0.07% |
72,998
-8,887
| -11% | -$360K |
|
341
Verisk Analytics
VRSK
$24.9B
| $3.04M | 0.07% |
42,584
-3,545
| -8% | -$239K |
|
342
Jazz Pharmaceuticals
JAZZ
$15.8B
| $3.04M | 0.07% |
17,577
-1,142
| -6% | -$196K |
|
343
Capri Holdings
CPRI
$1.87B
| $3.04M | 0.07% |
46,180
-3,119
| -6% | -$214K |
|
344
Royal Caribbean
RCL
$87.2B
| $3.02M | 0.07% |
36,957
-3,028
| -8% | -$240K |
|
|
AMTD
345
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3.02M | 0.07% |
81,051
-3,008
| -4% | -$107K |
|
346
ServiceNow
NOW
$119B
| $3.02M | 0.07% |
191,345
-13,920
| -7% | -$205K |
|
347
Stanley Black & Decker
SWK
$15.1B
| $3.01M | 0.07% |
31,564
-4,148
| -12% | -$397K |
|
348
Clorox
CLX
$12.2B
| $3M | 0.07% |
27,170
-3,025
| -10% | -$328K |
|
349
Autodesk
ADSK
$49.6B
| $2.98M | 0.07% |
50,877
-4,768
| -9% | -$282K |
|
350
Annaly Capital Management
NLY
$17.1B
| $2.96M | 0.07% |
69,165
-5,184
| -7% | -$220K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.